• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 759-773 of 1,115 results

2008 Exhibit: File History of US Patent 10,857,205 Part 7 of 7

Document IPR2022-01524, No. 2008-7 Exhibit - File History of US Patent 10,857,205 Part 7 of 7 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2020 Exhibit: Jaffe et al, Differential Response to Anti VEGF Regimens in Age Rela...

Document IPR2022-01524, No. 2020 Exhibit - Jaffe et al, Differential Response to Anti VEGF Regimens in Age Related Macular Degeneration Patients with Early Persistent Retinal Fluid, 123 OPHTHALMOL...

cite Cite Document
Analyze

2025 Exhibit: Mansour et al, Long term Visual Outcomes of Intravitreal Bevacizuma...

Document IPR2022-01524, No. 2025 Exhibit - Mansour et al, Long term Visual Outcomes of Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization, 148 AM J OPTHAMOLOGY 310 2009 (P.T...

cite Cite Document
Analyze

2027 Exhibit: Motion Requesting Expedited Status Conference, Regeneron Pharm...

Document IPR2022-01524, No. 2027 Exhibit - Motion Requesting Expedited Status Conference, Regeneron Pharms, Inc v Mylan Pharms Inc, Case No 122 cv 00061 TSK (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2021 Exhibit: Expert Declaration of Lucian V Del Priore, MD, PhD Redacted Copy, M...

Document IPR2022-01524, No. 2021 Exhibit - Expert Declaration of Lucian V Del Priore, MD, PhD Redacted Copy, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 00881, Exhibit No 2048 (P.T.A.B. D...

cite Cite Document
Analyze

2003 Exhibit: Decision, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 0088...

Document IPR2022-01524, No. 2003 Exhibit - Decision, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 00881 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2026 Exhibit: Lott et al, Bevacizumab in Inflammatory Eye Disease, 148 AM J OPTH...

Document IPR2022-01524, No. 2026 Exhibit - Lott et al, Bevacizumab in Inflammatory Eye Disease, 148 AM J OPTHAMOLOGY 711 2009 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2030 Exhibit: Petition for Inter Partes Review of US Patent No 9,669,069 B2, Apote...

Document IPR2022-01524, No. 2030 Exhibit - Petition for Inter Partes Review of US Patent No 9,669,069 B2, Apotex Inc v Regeneron Pharms, Inc, IPR2022 00301 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2011 Exhibit: File History of US Patent Application 17112,404

Document IPR2022-01524, No. 2011 Exhibit - File History of US Patent Application 17112,404 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2010 Exhibit: File History of US Patent Application 17072,417

Document IPR2022-01524, No. 2010 Exhibit - File History of US Patent Application 17072,417 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2032 Exhibit: etition for Inter Partes Review of US Patent No 9,254,338 B2, Apotex...

Document IPR2022-01524, No. 2032 Exhibit - etition for Inter Partes Review of US Patent No 9,254,338 B2, Apotex Inc v Regeneron Pharms, Inc, IPR2022 00298 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2023 Exhibit: Transcript Jan 20, 2022 Deposition of Thomas Albini, MD in Mylan Ph...

Document IPR2022-01524, No. 2023 Exhibit - Transcript Jan 20, 2022 Deposition of Thomas Albini, MD in Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 00880 IPR2021 00881 (P.T.A.B. Dec. 23, 2...

cite Cite Document
Analyze

2001 Exhibit: Scheduling Order, Regeneron Pharms, Inc v Mylan Pharms Inc, Case...

Document IPR2022-01524, No. 2001 Exhibit - Scheduling Order, Regeneron Pharms, Inc v Mylan Pharms Inc, Case No 122 cv 00061 TSK (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2028 Exhibit: Regeneron’s Opening Claim Construction Brief, Regeneron Pharms,...

Document IPR2022-01524, No. 2028 Exhibit - Regeneron’s Opening Claim Construction Brief, Regeneron Pharms, Inc v Mylan Pharms Inc, Case No 122 cv 00061 TSK (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze

2004 Exhibit: Decision, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 0088...

Document IPR2022-01524, No. 2004 Exhibit - Decision, Mylan Pharms Inc v Regeneron Pharms, Inc, IPR2021 00880 (P.T.A.B. Dec. 23, 2022)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 51 52 53 54 55 ... >>